Soluble IL-6 receptors in the serum and cerebrospinal fluid of paranoid schizophrenic patients (Q84447038)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19698539%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

title

Soluble IL-6 receptors in the serum and cerebrospinal fluid of paranoid schizophrenic patients (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19698539%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

1 reference

N Müller

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19698539%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

P Dobmeier

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19698539%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

M Empl

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19698539%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

M Riedel

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19698539%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

M Schwarz

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19698539%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

M Ackenheil

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19698539%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

publication date

1 January 1997

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19698539%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19698539%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

volume

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19698539%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19698539%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

page(s)

294-299

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19698539%20AND%20SRC:MED&resulttype=core&format=json

Systemic cytokine administration can affect blood-brain barrier permeability in the rat

6 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2897%2984789-X

7 January 2021

Serum interleukin-6 concentration in schizophrenia: elevation associated with duration of illness

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2897%2984789-X

7 January 2021

Production of interferons and lymphokines in leukocyte cultures of patients with schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2897%2984789-X

7 January 2021

TNF alpha induces IL-6 production by astrocytes but not by microglia.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2897%2984789-X

7 January 2021

Immune-inflammatory markers in schizophrenia: comparison to normal controls and effects of clozapine

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2897%2984789-X

7 January 2021

Cellular immunity in schizophrenic patients before and during neuroleptic treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2897%2984789-X

7 January 2021

Blood-cerebrospinal fluid barrier in schizophrenic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2897%2984789-X

7 January 2021

Elevated CSF levels of interleukin-2 in neuroleptic-free schizophrenic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2897%2984789-X

7 January 2021

Increases in CSF levels of interleukin-2 in schizophrenia: effects of recurrence of psychosis and medication status

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2897%2984789-X

7 January 2021

Evidence for an immune response in major depression: a review and hypothesis

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2897%2984789-X

7 January 2021

Relationships between lower plasma L-tryptophan levels and immune-inflammatory variables in depression

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2897%2984789-X

7 January 2021

The essential role of B cell stimulatory factor 2 (BSF-2/IL-6) for the terminal differentiation of B cells

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2897%2984789-X

7 January 2021

Cytokine-specific central monoamine alterations induced by interleukin-1, -2 and -6.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2897%2984789-X

7 January 2021

Diurnal variations of plasma interleukin-6 in man: methodological implications of continuous use of indwelling cannulae

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2897%2984789-X

7 January 2021

Soluble interleukin-6 (IL-6) receptor augments central effects of IL-6 in vivo.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2897%2984789-X

7 January 2021

Penetration of interleukin-6 across the murine blood-brain barrier

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2897%2984789-X

7 January 2021

The influence of cytokines on the integrity of the blood-brain barrier in vitro.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2897%2984789-X

7 January 2021

On the cellular source and function of interleukin 6 produced in the central nervous system in viral diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2897%2984789-X

7 January 2021

Natural autoantibodies in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2897%2984789-X

7 January 2021

Interleukin-6 improves the survival of mesencephalic catecholaminergic and septal cholinergic neurons from postnatal, two-week-old rats in cultures

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2897%2984789-X

7 January 2021

Abnormal cerebrospinal fluid protein indices in schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2897%2984789-X

7 January 2021

Relationships between interleukin-6 activity, acute phase proteins, and function of the hypothalamic-pituitary-adrenal axis in severe depression

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2897%2984789-X

7 January 2021

Immunoendocrine aspects of major depression

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2897%2984789-X

7 January 2021

Investigations of the cellular immunity during depression and the free interval: evidence for an immune activation in affective psychosis

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2897%2984789-X

7 January 2021

Interleukin-2 and interleukin-6 in schizophrenia and mania: Effects of neuroleptics and mood stabilizers

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2897%2984789-X

7 January 2021

Immunoglobulin and albumin content of cerebrospinal fluid in schizophrenic patients: relationship to negative symptomatology

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2897%2984789-X

7 January 2021

A comprehensive macrophage-T-lymphocyte theory of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2897%2984789-X

7 January 2021

Immunoregulators in the nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2897%2984789-X

7 January 2021

10.1016/S0924-9338(97)84789-X

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19698539%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

1 reference